EGFR, HER2 and HER3 dimerization patterns guide targeted inhibition in two histotypes of esophageal cancer.
about
Molecular predictive markers in tumors of the gastrointestinal tractAntitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinomaOptofluidic device for the quantification of circulating tumor cells in breast cancer.Molecular markers and imaging tools to identify malignant potential in Barrett's esophagusThe prognostic value of EGFR overexpression and amplification in Esophageal squamous cell Carcinoma.HER3 Expression Is a Marker of Tumor Progression in Premalignant Lesions of the Gastroesophageal Junction.High EGFR and low p-Akt expression is associated with better outcome after nimotuzumab-containing treatment in esophageal cancer patients: preliminary clinical result and testable hypothesis.Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma.Histone modifiers and marks define heterogeneous groups of colorectal carcinomas and affect responses to HDAC inhibitors in vitro.MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma.ATM mutations and E-cadherin expression define sensitivity to EGFR-targeted therapy in colorectal cancer.Pertuzumab in gastrointestinal cancer.Neratinib resistance and cross-resistance to other HER2-targeted drugs due to increased activity of metabolism enzyme cytochrome P4503A4.Tyrosine kinase inhibitor induced growth factor receptor upregulation enhances the efficacy of near-infrared targeted photodynamic therapy in esophageal adenocarcinoma cell lines.Response of esophageal cancer cells to epigenetic inhibitors is mediated via altered thioredoxin activity.Synergistic effect of targeting the epidermal growth factor receptor and hyaluronan synthesis in oesophageal squamous cell carcinoma cells.Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and AzacytidineSubcellular localization of EGFR in esophageal carcinoma cell lines.Anti-proliferative and pro-apoptotic effects induced by simultaneous inactivation of HER1 and HER2 through endogenous polyclonal antibodies.A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.WNT and NOTCH signaling pathways as activators for epidermal growth factor receptor in esophageal squamous cell carcinoma
P2860
Q28070583-4A4BDECF-8BC4-4031-AF5B-9657EA1D7C24Q33709855-CD8769D3-03C8-424B-8160-7BA77E47DDE2Q33808137-9766361F-563A-43FD-989D-2F63CC233CC6Q34508850-D4F31C51-869A-422E-A3EA-067201FC6288Q35624456-9AB20363-F0F2-4A1E-B7A0-2DE6CA8A3745Q36112574-131FA385-D8AB-446F-B28E-AFD44E89D9E3Q36210986-7FB3977E-0140-46BC-8401-46B33F242992Q36547753-B92D53D2-D490-4004-8B79-97A104EBF3BFQ36853881-19F09710-DA4C-4006-9409-245A113D1D56Q37457633-6A57A88B-FD60-49C6-9D80-F1CE82FCECE2Q37725589-7AF97495-A3AB-451E-816D-DEC1D8881E14Q38653309-752001A9-8973-4E66-9C2B-CC3757EEA419Q38718320-C44501DB-7EE6-45FA-B578-E742DCE06FDCQ38729531-DAE32277-101B-47E1-B0CF-DA87A3E82D47Q38809883-71CB256D-9933-4846-A5C5-C6F24A64C6F5Q38856978-9BD77803-F181-404A-9000-2EDCD2BD5DE4Q38881033-ABDD43E3-7188-4B30-8277-49588F6CC3FBQ40784649-7DB8924C-01DA-4D8A-B8E9-9D9C040F1488Q47111722-8CE268AD-BEF0-4077-A8EF-0093AB7AB637Q47757344-8B95F0E0-AFCB-434A-A80D-4F44FDECBF25Q57193567-BFCCAA39-721A-451E-AD2D-9869AD90D42A
P2860
EGFR, HER2 and HER3 dimerization patterns guide targeted inhibition in two histotypes of esophageal cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
EGFR, HER2 and HER3 dimerizati ...... stotypes of esophageal cancer.
@en
type
label
EGFR, HER2 and HER3 dimerizati ...... stotypes of esophageal cancer.
@en
prefLabel
EGFR, HER2 and HER3 dimerizati ...... stotypes of esophageal cancer.
@en
P2093
P2860
P356
P1476
EGFR, HER2 and HER3 dimerizati ...... stotypes of esophageal cancer.
@en
P2093
Anja Schöpflin
Christiane Daniela Fichter
David Klimstra
Dieter Hauschke
Gerhard Faller
Helene Geddert
Julia Alexandra Braun
Laura Tang
Lioudmilla Bogatyreva
Martin Werner
P2860
P304
P356
10.1002/IJC.28771
P577
2014-04-02T00:00:00Z